Literature DB >> 27906464

Methodological Considerations for Optimizing and Validating Behavioral Assays.

Stacey J Sukoff Rizzo1, Jill L Silverman2.   

Abstract

Preclinical animal models are indispensable tools for translational research for which behavioral characterization and phenotyping are essential to testing hypotheses and for evaluating the potential of novel therapeutic agents to treat diseases. The methods employed for comprehensive behavioral phenotyping and pharmacological experiments are complex and should be conducted exclusively by trained technicians with demonstrated proficiency. The ultimate goal is to identify disease-relevant and translational behavioral endpoints that are robust, reliable, and reproducible, and that can be employed to evaluate potential of novel therapeutic agents to treat disease. The intent of the present article is to provide a pragmatic outline for establishing and optimizing behavioral assays and phenotyping batteries, ensuring that the assays and the data are reliable such that they can be reproduced within and across technicians and laboratories and, more importantly, that the data is translatable to the clinic. © 2016 by John Wiley & Sons, Inc.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Keywords:  animal models; assay validation; behavior; behavioral testing; mouse; pharmacology; phenotyping; reproducibility

Mesh:

Year:  2016        PMID: 27906464      PMCID: PMC6054129          DOI: 10.1002/cpmo.17

Source DB:  PubMed          Journal:  Curr Protoc Mouse Biol        ISSN: 2161-2617


  61 in total

1.  The use of behavioral test batteries: effects of training history.

Authors:  K L McIlwain; M Y Merriweather; L A Yuva-Paylor; R Paylor
Journal:  Physiol Behav       Date:  2001-08

2.  The use of behavioral test batteries, II: effect of test interval.

Authors:  Richard Paylor; Corinne M Spencer; Lisa A Yuva-Paylor; Sandra Pieke-Dahl
Journal:  Physiol Behav       Date:  2005-09-28

3.  Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse.

Authors:  Vincent Castagné; Roger D Porsolt; Paul Moser
Journal:  Eur J Pharmacol       Date:  2009-06-21       Impact factor: 4.432

4.  Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study.

Authors:  Silvia Mandillo; Valter Tucci; Sabine M Hölter; Hamid Meziane; Mumna Al Banchaabouchi; Magdalena Kallnik; Heena V Lad; Patrick M Nolan; Abdel-Mouttalib Ouagazzal; Emma L Coghill; Karin Gale; Elisabetta Golini; Sylvie Jacquot; Wojtek Krezel; Andy Parker; Fabrice Riet; Ilka Schneider; Daniela Marazziti; Johan Auwerx; Steve D M Brown; Pierre Chambon; Nadia Rosenthal; Glauco Tocchini-Valentini; Wolfgang Wurst
Journal:  Physiol Genomics       Date:  2008-05-27       Impact factor: 3.107

Review 5.  Future viable models of psychiatry drug discovery in pharma.

Authors:  Stacey J Sukoff Rizzo; Jeremy R Edgerton; Zoë A Hughes; Nicholas J Brandon
Journal:  J Biomol Screen       Date:  2013-02-07

6.  Lack of association of a spontaneous mutation of the Chrm2 gene with behavioral and physiologic phenotypic differences in inbred mice.

Authors:  Ming Ding; Jennifer Arnold; Jeremy Turner; Vickram Ramkumar; Larry F Hughes; Rita A Trammell; Linda A Toth
Journal:  Comp Med       Date:  2010-08       Impact factor: 0.982

Review 7.  The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies.

Authors:  Inge Klinkenberg; Arjan Blokland
Journal:  Neurosci Biobehav Rev       Date:  2010-04-14       Impact factor: 8.989

8.  Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice.

Authors:  G Griebel; C Belzung; G Perrault; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  2000-02       Impact factor: 4.530

Review 9.  In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice.

Authors:  J F Cryan; C Mombereau
Journal:  Mol Psychiatry       Date:  2004-04       Impact factor: 15.992

10.  A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains.

Authors:  Michelle M Simon; Simon Greenaway; Jacqueline K White; Helmut Fuchs; Valérie Gailus-Durner; Sara Wells; Tania Sorg; Kim Wong; Elodie Bedu; Elizabeth J Cartwright; Romain Dacquin; Sophia Djebali; Jeanne Estabel; Jochen Graw; Neil J Ingham; Ian J Jackson; Andreas Lengeling; Silvia Mandillo; Jacqueline Marvel; Hamid Meziane; Frédéric Preitner; Oliver Puk; Michel Roux; David J Adams; Sarah Atkins; Abdel Ayadi; Lore Becker; Andrew Blake; Debra Brooker; Heather Cater; Marie-France Champy; Roy Combe; Petr Danecek; Armida di Fenza; Hilary Gates; Anna-Karin Gerdin; Elisabetta Golini; John M Hancock; Wolfgang Hans; Sabine M Hölter; Tertius Hough; Pierre Jurdic; Thomas M Keane; Hugh Morgan; Werner Müller; Frauke Neff; George Nicholson; Bastian Pasche; Laura-Anne Roberson; Jan Rozman; Mark Sanderson; Luis Santos; Mohammed Selloum; Carl Shannon; Anne Southwell; Glauco P Tocchini-Valentini; Valerie E Vancollie; Henrik Westerberg; Wolfgang Wurst; Min Zi; Binnaz Yalcin; Ramiro Ramirez-Solis; Karen P Steel; Ann-Marie Mallon; Martin Hrabě de Angelis; Yann Herault; Steve D M Brown
Journal:  Genome Biol       Date:  2013-07-31       Impact factor: 13.583

View more
  18 in total

1.  An active avoidance behavioral paradigm for use in a mild closed head model of traumatic brain injury in mice.

Authors:  Teresa Macheda; Henry C Snider; James B Watson; Kelly N Roberts; Adam D Bachstetter
Journal:  J Neurosci Methods       Date:  2020-06-24       Impact factor: 2.390

2.  Genetic backgrounds have unique seizure response profiles and behavioral outcomes following convulsant administration.

Authors:  Nycole Ashley Copping; Anna Adhikari; Stela Pavlova Petkova; Jill Lynn Silverman
Journal:  Epilepsy Behav       Date:  2019-11-04       Impact factor: 2.937

Review 3.  Loss of skills and onset patterns in neurodevelopmental disorders: Understanding the neurobiological mechanisms.

Authors:  Audrey Thurm; Elizabeth M Powell; Jeffrey L Neul; Ann Wagner; Lonnie Zwaigenbaum
Journal:  Autism Res       Date:  2017-12-11       Impact factor: 5.216

Review 4.  Behavioral and neuroanatomical approaches in models of neurodevelopmental disorders: opportunities for translation.

Authors:  Jill L Silverman; Jacob Ellegood
Journal:  Curr Opin Neurol       Date:  2018-04       Impact factor: 5.710

Review 5.  Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome.

Authors:  Anna Adhikari; Nycole A Copping; Beth Onaga; Michael C Pride; Rochelle L Coulson; Mu Yang; Dag H Yasui; Janine M LaSalle; Jill L Silverman
Journal:  Neurobiol Learn Mem       Date:  2018-05-23       Impact factor: 2.877

Review 6.  Autistic traits in epilepsy models: Why, when and how?

Authors:  Jana Velíšková; Jill L Silverman; Melissa Benson; Pierre-Pascal Lenck-Santini
Journal:  Epilepsy Res       Date:  2018-05-18       Impact factor: 3.045

Review 7.  Reconsidering animal models used to study autism spectrum disorder: Current state and optimizing future.

Authors:  Jill L Silverman; Audrey Thurm; Sarah B Ethridge; Makayla M Soller; Stela P Petkova; Ted Abel; Melissa D Bauman; Edward S Brodkin; Hala Harony-Nicolas; Markus Wöhr; Alycia Halladay
Journal:  Genes Brain Behav       Date:  2022-03-14       Impact factor: 3.708

Review 8.  Perspectives on Cognitive Phenotypes and Models of Vascular Disease.

Authors:  Selen C Muratoglu; Marc F Charette; Stacey J Sukoff Rizzo; M Luisa Iruela-Arispe; Zorina S Galis; Adam S Greenstein; Alan Daugherty; Anne Joutel; Beth A Kozel; Donna M Wilcock; Emily C Collins; Farzaneh A Sorond; Gareth R Howell; Hyacinth I Hyacinth; Kent K C Lloyd; Kurt R Stenmark; Manfred Boehm; Mark L Kahn; Roderick Corriveau; Sara Wells; Timothy J Bussey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-05-05       Impact factor: 10.514

9.  Developmental social communication deficits in the Shank3 rat model of phelan-mcdermid syndrome and autism spectrum disorder.

Authors:  Elizabeth L Berg; Nycole A Copping; Josef K Rivera; Michael C Pride; Milo Careaga; Melissa D Bauman; Robert F Berman; Pamela J Lein; Hala Harony-Nicolas; Joseph D Buxbaum; Jacob Ellegood; Jason P Lerch; Markus Wöhr; Jill L Silverman
Journal:  Autism Res       Date:  2018-01-29       Impact factor: 5.216

10.  Cognitive dysfunction in mice lacking proper glucocorticoid receptor dimerization.

Authors:  Kelly Van Looveren; Michiel Van Boxelaere; Zsuzsanna Callaerts-Vegh; Claude Libert
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.